ORGANIC
LETTERS
2003
Vol. 5, No. 7
1067-1069
Solid-Phase Synthesis of Pyrazolines
and Isoxazolines with Sodium
Benzenesulfinate as a Traceless Linker
Yu Chen, Yulin Lam,* and Yee-Hing Lai
Department of Chemistry, National UniVersity of Singapore, 3 Science DriVe 3,
Singapore 117543
Received January 19, 2003
ABSTRACT
The preparation of pyrazoline and isoxazoline derivatives with traceless solid-phase sulfone linker strategy is described. Key steps involved
in the solid-phase synthetic procedure include (i) sulfinate S-alkylation, (ii) sulfone anion alkylation, (iii) γ-hydroxy sulfone f γ-ketosulfone
oxidation, and (iv) traceless product release via elimination−cyclization. A library of 12 pyrazolines and isoxazolines was synthesized.
An important feature of solid-phase organic synthesis (SPOS)
is the linker that attaches the compounds being synthesized
onto the solid support.1 Methods of immobilizing compounds
to the solid phase for combinatorial synthesis initially rely
upon traditional solid-phase peptide linkers, which resulted
in the release of carboxylic acids, esters, or amides from the
ester- or amide-bound substrate.2 The presence of these
appendages is acceptable if the final products embody these
functional groups. However, complications may arise if these
vestigial functionalities are redundant and affect the activities
of the compounds. In this regard, one of our interests is to
develop the sulfone linker via polystyrene/1% divinylbenzene
sodium sulfinate (1) as a traceless linker and explore new
applications for it in SPOS. Earlier reports from other
laboratories3,4 and ours5 have demonstrated the use of 1 as
a solid support for SPOS and shown the resulting sulfone
linker derived from 1 to be a versatile and robust tether that
offers a variety of on-resin functionalization or cleavage with
additional changes.
Compounds containing the pyrazoline or isoxazoline
moieties have diverse activities6 and have been developed
as antiinflammatory agents,7 human leukocyte elastase
inhibitors,8 optical brighteners,9 fluorescent switches,10 and
intermediates of various biologically important compounds.11
Although the solid-phase synthesis of isoxazoline with 1,3-
dipolar cycloaddition has been extensively studied,3b,12
examples of their solid-phase synthesis with R,â-unsaturated
(4) (a) Huang, W.; Cheng, S.; Sun, W. Tetrahedron Lett. 2001, 42, 1973-
1974. (b) Farrall, M. J.; Frechet, J. M. J. Org. Chem. 1976, 41, 3877. (c)
Fyles, T. M.; Leznoff, C. C. Can J. Chem. 1976, 54, 935. (d) Fyles, T. M.;
Leznoff, C. C. Can. J. Chem. 1978, 56, 1031.
(5) (a) Chen, Y.; Lam, Y. L.; Lai, Y. H. Org. Lett. 2002, 4, 3935-3937.
(b) Chen, Y.; Lam, Y. L.; Lee, S. Y. Chem. Lett. 2001, 3, 274-275.
(6) Vita-Finzi, P. The Chemistry of Heterocyclic Compounds; Wiley &
Sons: New York, 1991; Vol 4, Part 1, p 417.
(7) (a) Frigola, J.; Colombo, A.; Pares, J.; Martinez, L.; Sagarra, R.;
Roster, R. Eur. J. Med. Chem. 1989, 24, 435-445. (b) Copp, F. C.; Islip,
P. J.; Tateson, J. E. Biochem. Pharmacol. 1984, 33, 339-340.
(8) Groutas, W. C.; Venkataman, R.; Chong, L. S.; Yoder, J. E.; Epp, J.
B.; Stanga, M. A.; Kim, E. Bioorg. Med. Chem. 1995, 3, 125-128.
(9) Dorlars, A.; Schellhammer, C.; Schroeder, J. Angew. Chem., Int. Ed.
1975, 14, 665-679.
(10) Silva, A. P.; Gunaratne, H. Q. N.; Gunnlaugsson, T.; Nieuwenhuizen,
M. Chem. Commun. 1996, 1967-1968.
(11) Kozikowski, A. P. Acc. Chem. Res. 1984, 17, 410-416.
(1) Guillier, F.; Orain, D.; Bradley, M. Chem. ReV. 2000, 100, 2091-
2157.
(2) Bunin, B. A. The Combinatorial Index; Academic Press: San Diego,
CA, 1998; pp 9-76.
(3) (a) Cheng, W. C.; Kurth, M. J. J. Org. Chem. 2002, 67, 4387-4391.
(b) Cheng, W. C.; Wong, M.; Olmstead, M. M.; Kurth, M. J. Org. Lett.
2002, 4, 741-744. (c) Cheng, W. C.; Lin, C. C.; Kurth, M. J. Tetrahedron
Lett. 2002, 43, 2967-2970. (d) Cheng, W. C.; Olmstead, M. M.; Kurth,
M. J. J. Org. Chem. 2001, 66, 5528. (e) Cheng, W. C.; Halm, C.; Evarts,
J. B.; Olmstead, M. M.; Kurth, M. J. J. Org. Chem. 1999, 64, 8557. (f)
Halm, C.; Evarts, J.; Kurth, M. J. Tetrahedron Lett. 1997, 38, 7709-7712.
10.1021/ol0340888 CCC: $25.00 © 2003 American Chemical Society
Published on Web 03/08/2003